Prolonged cell-cycle arrest associated with altered cdc2 kinase in monocrotaline pyrrole-treated pulmonary artery endothelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 19, Issue 1, 1998, Pages 129-142

  Thomas, Heath C ^a,b   Lamé, Michael W ^a   Morin, Dexter ^a   Wilson, Dennis W ^a   Segall, H J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; DRUG DERIVATIVE; MONOCROTALINE; MONOCROTALINE PYRROLE;

ANIMAL; ARTICLE; CATTLE; CELL CULTURE; CELL CYCLE G2 PHASE; CELL SIZE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MITOSIS; PHOSPHORYLATION; PULMONARY ARTERY; TIME; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CATTLE; CDC2 PROTEIN KINASE; CELL SIZE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; G2 PHASE; MITOSIS; MONOCROTALINE; PHOSPHORYLATION; PULMONARY ARTERY; TIME FACTORS;

EID: 0032113163     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.19.1.2895     Document Type: Article

References (45)

1. Lalich, J. J., and L. Merkow. 1961. Pulmonary arteritis produced in rats by feeding Crotolaria spectabilis. Lab. Invest. 10:744-750.
2. Wilson, D. W., H. J. Segall, L. C. Pan, M. W. Lamé, J. E. Estep, and D. Morin. 1992. Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit. Rev. Toxicol. 22:307-325.
3. Wilson, D. W., H. J. Segall, L. C. Pan, and S. K. Dunston. 1989. Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline treated rats. Microvasc. Res. 38:57-80.
4. Mattocks, A. R. 1968. Toxicity of pyrrolizidine alkaloids. Nature 217:723-728.
5. Segall, H. J., D. W. Wilson, M. W. Lamé, D. Morin, and C. K. Winter. 1991. Toxicology of plant and fungal compounds. In Handbook of Natural Toxins. R. F. Keeler and A. T. Tu, editors. Marcel Dekker, New York. 3-26.
6. 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. Am. J. Pathol. 106:84-94.
7. Hoorn, C. M . and R. A. Roth. 1992. Monocrotaline pyrrole alters DNA, RNA and protein synthesis in pulmonary artery endothelial cells. Am. J. Physiol. 262 L740-L747.
8. Bull, L. B., C C. J. Culvenor, and A. T. Dick. 1968. The pyrrolizidine alka-loids: their chemistry, pathogenecity and other biological properties. In Frontiers of Biology. A. Neuberger and E. L. Tatum, editors. North Holland Publishing Company. Amsterdam. 168-176.
9. Culvenor, C. C. J., D. T. Downing, J. A. Edgar, and M. V. Jago. 1969. Pyrrolizidine alkaloids as alkylating and antimitotic agents. Ann. NY Acad. Sci. 163:837-847.
10. Hsu, I.-C., C. F. Chesney, and J. R. Allen. 1973. Chronic effects of monocrotaline pyrrole on hepatic mitosis and DNA synthesis. Proc. Soc. Exp. Biol. Med 142:1133-1136.
11. Mattocks, A. R. 1986. Chemistry and Toxicology of Pyrrolizidine Alkaloids. Academic Press, Orlando, FL.
12. Hincks, J. R., H.-Y. Kim, H. J. Segall, R. J. Molyneux, F. R. Stermitz, and R. A. Coulombe. 1991. DNA cross-linking in mammalian cells by pyrrolizidine alkaloids: structure activity relationships. Toxicol. Appl. Pharmacol. 111:90-98.
13. Taylor, D. W., D. W. Wilson, M. W. Lamé, S. D. Dunston, A. D. Jones, and H. J. Segall. 1997. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells. Toxicol. Appl. Pharmacol. 143:196-204.
14. Wagner, J. G., T. W. Petry, and R. A. Roth. 1993. Characterization of monocrotaline pyrrole-induced DNA cross-linking in pulmonary artery endothelium. Am. J. Physiol. 264:L517-L522.
15. Thomas, H. C., M. W. Lamé, D. W. Wilson, and H. J. Segall. 1996. Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNA. Toxicol. Appl. Pharmacol. 141: 319-329.
16. Valdivia, E., J J. Lalich, Y. Hayashi, and J. Sonnad. 1967. Alterations in pulmonary alveoli after a single injection of monocrotaline. Arch. Pathol. 84:64-76.
17. Bruner, I., H. K. S. Hilliker, and R. A. Roth. 1983. Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat. Am. J. Physiol. 245:H300-H306.
18. Pines, J. 1995. Cyclins and cyclin-dependent kinases: theme and variations. Adv. Cancer Res. 66:181-212.
19. Norbury, C., J. Blow, and P. Nurse. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10:3321-3329.
20. O'Connor, P. M., D. K. Ferris, M. Pagano, G. Draetta, J. Pines, T. Hunter, D. L. Longo, and K. W. Kohn. 1993. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J. Biol. Chem. 268:8298-8308.
21. Tobey, R. A. 1975. Different drugs arrest cells at a number of distinct stages in G2. Nature 254:245-247.
22. Maity, A., W. G. McKenna, and R. J. Muschel. 1994. The molecular basis for cell cycle Jelays following ionizing radiation: a review. Radiother. Oncol. 31:1-13.
23. O'Connor, P. M., D. K. Ferris, I. Hoffmann, J. Jackman, G. Draetta, and K. W. Kohn. 1994. Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard. Proc. Natl. Acad. Sci. USA 91:9480-9484.
24. Muschel, R. J., H. B. Zhang, G. Haikis, and W. G. McKenna. 1991.Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res. 51:5113-5117.
25. Lamé, M. W., D. Morin, A. D. Jones, H. J. Segall, and D. W. Wilson. 1990. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline. Toxicol. Lett. 51:321-329.
26. Mattocks, A. R., R. Jukes, and J. Brown. 1989. Simple procedures tor preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon. 27: 561-567.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
28. Hall, P. A., and D. A. Levison. 1990. Review: assessment of cell proliferation in histological material. J. Clin. Pathol. 43:184-192.
29. Orlowski, C. C., and R. W. Furlanetto. 1996. The mammalian cell cycle in normal and abnormal growth. Endocrinol. Metab. Clin. North Am. 25:491-502.
30. O'Connor, P. M., D. K. Ferris, G. A. White, J. Pines, T. Hunter, D. L. Longo, and K. W. Kohn. 1992. Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ. 3:43-52.
31. Tsao, Y. P., P. D'Arpa, and L. F. Liu. 1992. The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/ cyclin B. Cancer Res. 52:1823-1824.
32. Metting, N. F., and J. B. Little. 1995. Transient failure to dephosphorylate the cdc2-cyclin B1 complex accompanies radiation-induced G2-phase arrest in HeLa cells. Radiat. Res. 143:286-292.
33. Reed, R. L., K. G. Ahern, G. D. Pearson, and D. R. Buhler. 1988. Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids. Carcinogenesis 9:1355-1361.
34. 6-alkylguanine-DNA alkyltransferase in human lymphocytes after nitrosourea exposure. Cancer Res. 48:5368-5373.
35. Mallery, S. R., L. E. Lantry, H. B. Laufman, R. E. Stephens, and G. P. Brierley. 1993. Modulation of human microvascular endothelial cell bioenergetic status and glutathione levels during proliferative and differentiated growth. J. Cell Biochem. 53:360-372.
36. Paulovich, A. G., and L. H. Hartwell. 1995. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell 82:841-847.
37. Wilson, D. W., and H. J. Segall. 1990. Changes in type II cell populations in monocrotaline pneumotoxicity. Am. J. Pathol. 136:1293-1299.
38. Sugita, T., T. M. Hyers, I. M. Dauber, W. W. Wagner, I. F. McMurtry, and J. T. Reeves. 1983. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J. Appl. Physiol. 54:371-374.
39. Butler, W. H. 1970. An ultrastructural study of the pulmonary lesion induced by pyrrole derivatives of the pyrrolizidine alkaloids. J. Pathol. 102: 15-19.
40. Reindel, J. F., P. E. Ganey, J. G. Wagner, R. F. Slocombe, and R. A. Roth. 1990. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Toxicol. Appl. Pharmacol. 106:179-200.
41. Reindel, J. F., and R. A. Roth. 1991. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells. Am. J. Pathol. 138:707-719.
42. Jones, P. L., and M. Rabinovitch. 1996. Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation. Circ. Res. 79:1131-1142.
43. Tuder, R. M., B. Groves, D. B. Badesch, and N. F. Voelkel. 1994. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension. Am. J. Pathol. 144:275-285.
44. Loscalzo, J. 1992. Endothelial dysfunction in pulmonary hypertension. N. Engl. J. Med. 327:117-119.
45. Hilliker, K. S., T. G. Bell, and R. A. Roth. 1982. Pneumotoxicity and thrombocytopenia after single injection of monocrotaline. Am. J. Physiol. 242: H573-H579.